Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Oldfield

Showing results (121-130 of 198) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|January 10, 2015
Antibacterial drug leads: DNA and enzyme multitargetingWei Zhu, Yang Wang, Kai Li, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic BisphosphonatesGyongseon Yang, Wei Zhu, Kuglae Kim, et al.
Science (New York, N.Y.)|February 16, 2008
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulenceChia-I Liu, George Y Liu, Yongcheng Song, et al.
ACS Infectious Diseases|August 22, 2015
In Vitro and in Vivo Activity of Multitarget Inhibitors against Trypanosoma bruceiGyongseon Yang, Wei Zhu, Yang Wang, et al.
Journal of the American Chemical Society|August 17, 2016
A Highly Efficient Single-Chain Metal-Organic Nanoparticle Catalyst for Alkyne-Azide "Click" Reactions in Water and in CellsYugang Bai, Xinxin Feng, Hang Xing, et al.
Journal of the American Chemical Society|October 13, 2006
Solid-state NMR of a paramagnetic DIAD-FeII catalyst: sensitivity, resolution enhancement, and structure-based assignmentsGwendal Kervern, Guido Pintacuda, Yong Zhang, et al.
Chemical Biology & Drug Design|October 30, 2014
A Molecular Dynamics Investigation of Mycobacterium tuberculosis Prenyl Synthases: Conformational Flexibility and Implications for Computer-aided Drug DiscoveryMeekyum Olivia Kim, Xinxin Feng, Ferran Feixas, et al.
Mbio|September 21, 2022
The Heptaprenyl Diphosphate Synthase (Coq1) Is the Target of a Lipophilic Bisphosphonate That Protects Mice against Toxoplasma gondii InfectionMelissa A Sleda, Zhu-Hong Li, Ranjan Behera, et al.
Chemmedchem|February 1, 2012
Dual dehydrosqualene/squalene synthase inhibitors: leads for innate immune system-based therapeuticsFu-Yang Lin, Yonghui Zhang, Mary Hensler, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondiiVanessa Yardley, Anis A Khan, Michael B Martin, et al.
Pageof 20

Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|January 10, 2015
Antibacterial drug leads: DNA and enzyme multitargetingWei Zhu, Yang Wang, Kai Li, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic BisphosphonatesGyongseon Yang, Wei Zhu, Kuglae Kim, et al.
Science (New York, N.Y.)|February 16, 2008
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulenceChia-I Liu, George Y Liu, Yongcheng Song, et al.
ACS Infectious Diseases|August 22, 2015
In Vitro and in Vivo Activity of Multitarget Inhibitors against Trypanosoma bruceiGyongseon Yang, Wei Zhu, Yang Wang, et al.
Journal of the American Chemical Society|August 17, 2016
A Highly Efficient Single-Chain Metal-Organic Nanoparticle Catalyst for Alkyne-Azide "Click" Reactions in Water and in CellsYugang Bai, Xinxin Feng, Hang Xing, et al.
Journal of the American Chemical Society|October 13, 2006
Solid-state NMR of a paramagnetic DIAD-FeII catalyst: sensitivity, resolution enhancement, and structure-based assignmentsGwendal Kervern, Guido Pintacuda, Yong Zhang, et al.
Chemical Biology & Drug Design|October 30, 2014
A Molecular Dynamics Investigation of Mycobacterium tuberculosis Prenyl Synthases: Conformational Flexibility and Implications for Computer-aided Drug DiscoveryMeekyum Olivia Kim, Xinxin Feng, Ferran Feixas, et al.
Mbio|September 21, 2022
The Heptaprenyl Diphosphate Synthase (Coq1) Is the Target of a Lipophilic Bisphosphonate That Protects Mice against Toxoplasma gondii InfectionMelissa A Sleda, Zhu-Hong Li, Ranjan Behera, et al.
Chemmedchem|February 1, 2012
Dual dehydrosqualene/squalene synthase inhibitors: leads for innate immune system-based therapeuticsFu-Yang Lin, Yonghui Zhang, Mary Hensler, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondiiVanessa Yardley, Anis A Khan, Michael B Martin, et al.
Pageof 20